Digital Health
Ropes & Gray has extensive experience working with a range of clients in the digital health industry, from pharmaceutical companies, medical device manufacturers, big data companies, mobile application developers, and the financial institutions investing in these companies, to hospitals and health care enterprise administrators and insurance providers. With capabilities that support businesses at the intersection of digital health consumers and vendors, we possess a keen understanding of the interplay between the business demands of our clients, the rapidly evolving regulatory landscape, and established industry practices. In the past few years, our multidisciplinary team has guided clients through transactions totaling more than $10 billion in the digital health industry, and we have assisted digital health clients in securing $832 million in financing. Drawing on the experience and knowledge of our attorneys across the firm’s health care, privacy, life sciences, M&A, finance, and litigation groups, our lawyers advise clients on the most critical aspects of operating in the digital health industry.
Alerts
- Cures Are on the House: House Passes 21st Century Cures Act, but Senate Awaits
(July 23, 2015) - 21st Century Cures Act – Provisions Relating to Digital Health: Interoperability and Information Blocking
(July 2015) - FDA Draft Guidances on General Wellness Products and Device Accessories Continue Risk-Based Approach to Health IT
(January 26, 2015) - FDA Final Guidance Confirms Role of Medical Device Firms in Cybersecurity Management
(October 3, 2014) -
Final Guidance on 2014 Certified EHR Technology Requirements and Implementation of Stage 3 Meaningful Use Requirements
(September 5, 2014) - CMS and ONC Issue Proposed Rule Modifying 2014 Requirements for EHR Incentive Programs and Certified EHR Technology
(May 27, 2014)